002022 Shanghai Kehua Bio-engineering
- 6.74
- -0.08-1.17%
Shanghai Kehua Bio-engineering News
Kehua Biotech: Announcement of Resolutions of the 7th Meeting of the 10th Board of Supervisors
Kehua Biotech: Announcement on proposed changes to accounting firms
Kehua Biotech: Announcement of Resolutions of the 9th Meeting of the 10th Board of Directors
Kehua Biotech: Financial Management System (Revised in October 2024)
Kehua Biotech: Announcement of Board Resolutions
Kehua Biotech: Announcement of Supervisory Board Resolutions
Kehua Biotech: Investment Management System (Revised in October 2024)
Kehua Biotech: Announcement on the product obtaining a medical device registration certificate
Kehua Biotech: Announcement of Resolutions of the 7th Meeting of the 10th Board of Directors
Kehua Biotech: CITIC Securities Co., Ltd.\'s inspection opinions on adding implementing entities, implementation locations, and adjusting investment composition details for some fund-raising projects of Shanghai Kehua Bioengineering Co., Ltd., and the extension of some fund-raising projects
Kehua Biotech: Announcement of Resolutions of the Fifth Meeting of the 10th Board of Supervisors
Kehua Biotech: Investor Relations Activity Record Form for September 6, 2024
Kehua Biotech: Announcement of Supervisory Board Resolutions in the Semi-Annual Report
Kehua Biotech: Semi-Annual Report Board Resolution Announcement
Kehua Biotech: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Shanghai Kehua Bio-engineering: Announcement about the product obtaining the medical instruments registration certificate.
Shanghai Kehua Bio-engineering: Announcement about the product obtaining the medical instruments registration certificate.
Shanghai Kehua Bio-engineering: Announcement of Resolution of the Fifth Meeting of the Tenth Board of Directors.
Shanghai Kehua Bio-engineering: Announcement about the product obtaining the medical instruments registration certificate.
Shanghai Kehua Bio-engineering: Investor Relations Event Log for July 3, 2024
Analysis
Price Target
No Data
No Data